“…However, it is very likely that a public healthcare service may be able to negotiate discounts on the costs of FLACS, especially if used within a high-volume service (which further improves affordability) (tables 7 and 8). Further cost savings may be made by improved safety which may make cost savings in postoperative management 20. It is important to note therefore that while there was no difference in PCR and vitreous loss rates in this arm of this study to investigate comparative high-volume hub-and-spoke FLACS and CPS theatres lists (table 6), the results of the overall RCT showed a statistically significant reduction in PCR with FLACS, in a public health setting with different grade of surgeons operating, including those in training (H. Roberts, D. O’Brart, personal communication, 2018).…”